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Seventeen patients underwent treatment for a pathological fracture of the proximal femur due to osteosarcoma. Their age range
was from 9 to 84 (mean age 42) with nine patients under the age of 40 and eight above the age of 40. Twelve patients had a fracture
at diagnosis and ﬁve developed a fracture after the diagnosis. Seven patients had metastatic disease at diagnosis. Five patients were
referred after internal ﬁxation of the fracture prior to diagnosis. Chemotherapy was used when appropriate and eight patients
then underwent limb salvage surgery, six had an amputation, and three had palliative treatment. The estimated ﬁve-year survival
was 14%. These results are signiﬁcantly worse than expected, and it proved impossible to identify any group who fared well. The
high incidence of metastases both at diagnosis and subsequently suggests this group of patients are at very high risk. Review of
multicentre data may suggest an optimum treatment for this patient group.
1.Introduction
Osteosarcoma is the commonest primary bone sarcoma
arising with an incidence of approximately 3 per million
population/year [8]. 70% of all osteosarcomas will arise
around the knee, but 5-6% arise in the proximal femur.
The incidence of pathological fracture in osteosarcoma is
from 5% to 12%. There are many reports on osteosarcoma
and pathological fracture, [1–16] most of these reports
only dealing with patients without metastases at diagnosis.
Pathological fracture can be the presenting feature or it can
occur during treatment. Progressive loss of bone matrix,
biopsy, and minor trauma are some of the reasons for
the occurrence of a pathological fracture. The presence of
a pathological fracture has been noted to be an adverse
prognostic factor in osteosarcoma by some authors [9]b u t
not by others [3, 5].
A pathological fracture of the proximal femur poses
particularproblems,becausethefracturehaematoma(which
has to be considered to contain tumour cells) may either
be intracapsular, thus contaminating the hip joint, or
extracapsular when there is likely to be widespread con-
tamination of surrounding tissues. Unlike the distal femur
or proximal tibia where fracture haematomas are often
contained by muscle (vastus intermedius and popliteus,
resp.), there is no such limiting muscle in the proximal
femur. Management is also diﬃcult because it is diﬃcult to
immobilise the fracture either in plaster or with traction and
continued movement at the fracture site during preoperative
chemotherapymayincreasetheriskofwiderlocalspreadand
possibly metastases. To our knowledge there is no published
study addressing the outcome of pathological fractures of
the proximal femur due to osteosarcoma, and the aim of the
present study was to address this speciﬁc problem.2 ISRN Oncology
Figure 1: Preoperative radiographs, MRI scan of osteosarcoma of the proximal femur, and postoperative radiograph showing proximal
femoral endoprosthesis.
2. Patientsand Methods
We retrospectively analysed data contained in a prospective
tumourdatabase.Weincludedallpatientswhohadadiagno-
sisofosteosarcomaoftheproximalfemurwithapathological
fracture. We included intracapsular, intertrochanteric, and
subtrochanteric fractures in the study.
Between 1978 and 2008, 1193 patients were diagnosed
and treated for osteosarcoma in our unit. 54 patients (4.5%)
had proximal femoral disease. Seventeen patients (31%)
presented with a fracture or sustained a fracture of the
proximal femur during the course of preoperative treatment.
All had staging studies including bone scan, MRI scan of
the proximal femur, and CT of the chest. (Figure 1)T i s s u e
diagnoses were obtained in all the cases, usually by needle
biopsy. Before operation, the fractures were immobilised by
traction with the patient being on bed rest. The patients
were oﬀered preoperative chemotherapy according to the
protocol in use at the time. In general, most patients under
t h ea g eo f6 0w e r eo ﬀered neoadjuvant chemotherapy, and
were then restaged prior to a decision being made about
surgery. Patients over the age of 60 usually had surgery (if
possible) without chemotherapy.
The decision as to the operation to be undertaken to
control the local disease was based on the local extent of
the tumour as seen on the imaging scans, the response to
preoperative chemotherapy and patient preference. Proxi-
mal femoral endoprostheses (Figure 1), hip disarticulation,
hindquarter amputation, and palliation were the treatment
options. We analyzed patient, tumour, and treatment factors
in relation to overall survival using Stat view software. Dif-
ferences between groups were assessed using Mann WhitneyISRN Oncology 3
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Figure 2: Kaplan Meier survival curve showing the survival of
patients split by age group. There is no statistical diﬀerence between
the two groups, despite the younger group all being treated with
chemotherapy (P = 0.17).
U-test. Survival was estimated using Kaplan Meier survival
curves with patients censored at the time of last followup.
Signiﬁcance was taken as P<0.05.
3. Results
Between 1978 and 2008, seventeen patients had a patho-
logical fracture of the proximal femur due to osteosarcoma.
There were thirteen males and four females. Their age range
was from 9 to 84 (mean age 42) with nine patients under
the age of 40 and eight above the age of 40. (Table 1)T w e l v e
patients had a fracture prior to diagnosis and ﬁve developed
a fracture after the diagnosis. Seven patients (41%) had
metastatic disease at diagnosis. Five patients were referred
after ﬁxation of the fracture prior to the diagnosis being
made(aslidinghipscrewﬁxationinfourandintramedullary
nail in one) of whom two had metastatic disease.
Two groups of patients were identiﬁed, those under the
age of 40 and those over that age. (Table 1) This age was
chosen as all of the younger group received chemotherapy
and were oﬀered surgery, whilst the older age group were
usually only treated surgically or by palliation.
In the younger group of patients (age range 9 to 39),
seven patients suﬀered fractures at the time of diagno-
sis and two later (one turning in bed and one stum-
bling on stairs). One patient had undergone nailing of
a subtrochanteric fracture before the diagnosis had been
made. Three patients had metastases at diagnosis. All were
treated with immobilization and traction for the fracture,
whilst they received neoadjuvant chemotherapy. Following
restaging after chemotherapy, four patients were treated
with endoprosthetic replacement of the proximal femur
and four with amputation (two hip disarticulation and two
hindquarteramputation).Onepatientdevelopedprogressive
diseasewithmetastaseswhilstonchemotherapyanddeclined
amputation, receiving palliative radiotherapy.
The margins of excision were judged to be wide in
three patients, marginal in three, and intralesional in two.
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Figure 3: Kaplan Meier Survival analysis—osteosarcoma of the
proximal femur with a pathological fracture—14% ﬁve-years
survival.
Only two patients (both of whom had limb salvage) were
found to have a good response to chemotherapy (>90%
necrosis). Postoperative radiotherapy was given to patients
with intralesional margins.
All but one of this group of patients under 40 developed
metastases (three had them at the time of diagnosis and
ﬁve others developed them at 6, 7, 9, 19, and 21 months
resp., following diagnosis). The only survivor in this group
was the one without metastasis—patient 8 (Table 1). This
patient had presented with a fractured proximal femur,
had it nailed, but then the diagnosis of osteosarcoma was
conﬁrmed. He had no metastases at diagnosis and had
progressive disease on chemotherapy leading to the need for
hindquarter amputation. He remains disease-free after 75
months. The median survival of this group of young patients
was 19 months with a one-year survival of 78%, two-year
survival of 42%, and ﬁve-year survival of 14% (Figure 2).
The older group of nine patients were all over the age
of 40, the youngest being 57 and the oldest 84 (Table 1).
Three of the patients had underlying Paget’s disease and ﬁve
had conventional osteosarcoma. Four of the eight had lung
metastases at the time of diagnosis (two of the three with
a Paget’s associated osteosarcoma) and four had undergone
previous internal ﬁxation for the fracture in the mistaken
belief that it was due to metastatic disease.
Only two of these patients had chemotherapy, and this
proved ineﬀective in both patients (20% necrosis in one and
25% in the other). Six of the eight underwent surgery with
two having primary amputation and four limb salvage with
an endoprosthesis. All of the patients eventually developed
metastaticdisease,withthefourwhodidnothavemetastases
at diagnosis developing them at 5, 6, 15, and 82 months
following diagnosis. All of these patients have since died of
their disease, the median survival being 9 months, the one-
yearsurvival37%,andﬁve-yearsurvival12%(Figure 2).The
o v e r a l ls u r v i v a lo ft h ew h o l eg r o u pw a s1 4 %a tﬁ v ey e a r s
(Figure 3).
Eight patients had limb salvage surgery with a prox-
imal femoral endoprosthesis, six patients underwent an4 ISRN Oncology
Table 1: Patient, treatment and outcome details.
No. Age Type
Duration
symptom
in weeks
Path fract Previous
treatment
Site of
fracture Surgery Chemo
protocol
Chemo
necrosis
Local
recurrence Mets Time
alive Status
1 9 M os 12 After diag none subtroch amp adria/cisplat 80 no LR 7 8 dead
21 2 Fo s 8 At time
diagnosis none subtroch amp adria/cisplat 30 no LR 6 13 dead
3 13 F os 32 After diag none intracap lss pam 100
LR 20
months Rx
RT
At
diag 38 dead
4 14 M os 8 After diag none subtroch lss pam 94 no LR At
diag 26 dead
51 7 Fo s 1 2 At time
diagnosis none subtroch lss adria/cisplat 80 no LR 19 22 dead
62 0 Mo s 1 2 At time
diagnosis none subtroch amp vcr/mtx no LR At
diag 8d e a d
72 6 Mo s 1 2 At time
diagnosis none intertroch pam 0 no LR 9 14 dead
8 32 M os 100 At time
diagnosis int ﬁx subtroch amp pam 25 no LR 75 alive
93 9 Mo s 8 At time
diagnosis none intracap lss RT adria/cisplat 20 no LR 21 28 dead
10 57 M pagets 25 After diag none subtroch amp no no LR 6 12 dead
11 62 F os After
diagn int ﬁx intertroch lss no no LR At
diag 5d e a d
12 62 F os 26 At time
diagnosis none intertroch lss RT no no LR 5 7 dead
13 65 M os 12 At time
diagnosis int ﬁx subtroch lss adria
LR 15
months Rx
Amp
82 109 dead
14 67 M os 26 At time
diagnosis int ﬁx intertroch lss no
LR 4
months Rx
Excise and
RT
15 15 dead
15 67 M pagets 104 At time
diagnosis none subtroch amp no no LR At
diag 10 dead
16 74 M os 40 At time
diagnosis int ﬁx intertroch no no At
diag 10 dead
17 84 M pagets 36 At time
diagnosis none subtroch no no At
diag 1d e a d
amputation (three hindquarter and three disarticulation),
and three had palliative treatment. Four patients had a
local recurrence—three of the eight (37.5%) who had limb
salvage surgery and one after hip disarticulation. There
was no diﬀerence in survival between patients treated with
amputation or limb salvage nor was there any diﬀerence
in survival between those with metastases at diagnosis and
those without, nor between those with fractures prior to
diagnosis or after diagnosis. Of the ﬁve patients who had
previous internal ﬁxation of the fracture, one underwent
primary amputation, three underwent limb salvage surgery,
and one had palliative treatment. The only survivor is one
who had a hindquarter amputation.
Two of the patients had intracapsular fractures, ﬁve had
intertrochanteric fracture and ten had a subtrochanteric
fracture. Again there was no diﬀerence in survival between
them nor was there any diﬀerence between those with pre-
vious ﬁxation of the fracture and those without (Figure 4).
Throughout the same time period of this study, the
overall ﬁve-year survival for all patients with nonmetastatic
osteosarcoma at our centre was 54% and for patients within
this group with proximal femoral osteosarcoma but without
a fracture was 51%.
4. Discussion
We have identiﬁed a group of patients with osteosarcoma
who appear to have a very poor prognosis. Patients with a
pathological fracture due to osteosarcoma of the proximal
femur represent just 1.4% of all patients with osteosarcomaISRN Oncology 5
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Figure 4: Kaplan Meier survival curve showing the survival of
patients split by early ﬁxation prior to diagnosis or no previous
ﬁxation. There was no statistical diﬀerence between the two groups
(P = 0.19).
in our dataset, and if only patients under the age of 40
are included (as in most studies of osteosarcoma) then the
proportion falls to under 1%.
Previous studies of osteosarcoma have identiﬁed a prox-
imal location as having a poor prognosis and other studies
have suggested that a pathological fracture oﬀers a poor
prognosis but the combination of the two has not previously
been shown to be such a dismal combination. Most studies
[1, 3, 5, 11–14] simply do not have enough patients to
identify a group as small as this. Similarly, osteosarcoma in
patients over the age of 40 has rarely been investigated with
one large study only having 34 patients with osteosarcoma of
the proximal femur, but no comment was made about their
survival or the signiﬁcance of a pathological fracture [1].
Thereasonwhypatientswithaproximalfemoralfracture
do so badly is not easy to explain when they seem to do so
much worse than patients with tumours at the same location
without fractures.
Firstly, seven of this group of seventeen patients already
had metastases at diagnosis (41%), a much higher propor-
tion than is normally seen in osteosarcoma patients (11% at
our institution). As these metastases will have seeded many
months before the fracture happened, this might suggest an
increased vulnerability of the location to metastasise and this
would need veriﬁcation in further studies.
Secondly, the risk of pathological fracture (31%) at this
site is considerably higher than for any other location in
the body, but this is probably simply a reﬂection on the
local anatomy whereby any process that weakens the bone
(e.g., osteoporosis) leads to an increased risk of proximal
femoral fracture. The most common type of fracture was
a subtrochanteric fracture, suggesting that most of the
osteosarcomas arose in this region. Subcapital fractures were
rarebutaﬀectedmanagementasthefracturehaematomawas
thus intracapsular. In that situation, the option of carrying
out an extraarticular resection as described by R¨ udiger et al.
[2] could be considered although none of the patients in this
series were treated in this way.
The main problem with proximal femoral fractures
due to osteosarcoma is the lack of containment of the
fracture haematoma by surrounding soft tissues. There is no
envelopingmuscletopreventwidespreadlocaldissemination
of haematoma and tumour cells, which is likely to track
around all of the surrounding area including psoas, the
glutei, adductors, and vasti. This means that any attempt at
subsequent excision may have compromised margins with
an increased risk of local recurrence. Five of our patients
had undergone internal ﬁxation of the fracture prior to the
diagnosis being made, and this resulted in further extensive
contamination of both bone and soft tissues with tumour
cells.
The management of this group of patients is diﬃcult.
The normal management of a pathological fracture in
osteosarcoma is to immobilize the fracture and administer
chemotherapy in the hope that the fracture will heal and
the fracture/tumour haematoma will become walled oﬀ,
thus allowing limb salvage [3]. In the proximal femur,
immobilization is diﬃcult if not impossible either with
tractionorbedrestaloneandcanprobablyonlybeimproved
by application of a hip spica plaster or external ﬁxation
from the pelvis to the femur. Thus it is likely that in most
cases there will be continuing movement at the fracture site,
and this may oﬀer an explanation for the high incidence of
subsequent development of metastases in sixteen patients.
If the fracture is internally ﬁxed, then this does allow the
patienttobemobilewhiletreatmentisconsidered,butonthe
other hand it will result in more widespread contamination
of normal tissues and will then require even more extensive
surgery to ensure clear margins can be obtained. In our ﬁve
cases who had early stabilisation, one required an amputa-
tion and three had limb salvage of whom two developed a
localrecurrence.Itwouldseem,therefore,thatamputationis
probably the only safe option following inadvertent ﬁxation
of a proximal femoral fracture in osteosarcoma unless there
is a good response to chemotherapy. The only two patients
in this series to survive more than ﬁve years had both
undergone ﬁxation of the fracture prior to diagnosis and
bothsubsequentlyhadamputation(onefollowingattempted
limb salvage and local recurrence).
Althoughtherehavebeennumerousotherpaperswritten
about pathological fractures in osteosarcoma, the numbers
with proximal femoral fractures were small and most papers
make no comment about them compared to other sites.
Scully et al. [4] in 2006 reported a 30% risk of local
recurrence and 60% two-year survival with limb salvage
and 66% two-year survival with early amputation in a
cohort of 16 patients with pathological fractures in non
metastatic osteosarcoma (the group included four patients
with a proximal femoral lesion). They did not ﬁnd any
statistically signiﬁcant diﬀerence in survival between early
amputation and limb salvage though there was 30% risk of
l o c a lr e c u r r e n c ew i t hl i m bs a l v a g e .
Scully et al. [5] in 2002 reported a multicentre case-
matched retrospective study comparing ﬁfty-two patients
with a pathological fracture with ﬁfty-ﬁve patients without a
pathological fracture. The group included patients with non
metastatic osteosarcoma, and the overall ﬁve-year survival6 ISRN Oncology
was55%.Thecohortincludedsevenpatientswithaproximal
femoral lesion. They also noted that three out of ﬁve patients
who had open reduction and internal ﬁxation followed by
limb salvage surgery were alive at an average of 6.1 years
postoperatively.
Bacci et al. [3] reported overall survival of 65% from a
cohortof46patientswithnonmetastaticosteosarcomaofthe
extremities of whom 22 had involvement of the femur, but
the number of proximal femoral lesions was not speciﬁed.
Given the rarity of this combination of proximal femoral
fracture in osteosarcoma, providing evidence-based guide-
lines is likely to be diﬃcult but based on our results thus far
we suggest the following.
We believe that a pathological fracture in osteosarcoma
of the proximal femur should be avoided at all cost. If there
isanextensivelyticprocesslikelytoleadtofracturefollowing
biopsy, very early surgery should be considered, possibly
doing a frozen section and being prepared to do a proximal
femoral replacement prior to chemotherapy if the lesion
is operable. The availability of modular endoprostheses
[6] and the fact that chemotherapy is just as eﬀective
if administered postoperatively as preoperatively [7]m a y
prevent the catastrophic complication of fracture.
If the fracture has already arisen and been inadvertently
stabilised, then the patient should be treated conventionally
with chemotherapy and reassessed. Limb salvage should
only be considered if there has been a good response to
chemotherapy.Amputationislikelytobethesafesttreatment
option.
The most diﬃcult group are those with an unstable
fracture. If chemotherapy is not an option then amputation
shouldbeconsideredfollowingdiagnosis.Ifchemotherapyis
being used (under the age of 60), then it should only be given
preoperatively if the fracture can be completely immobilized
and a good response is likely to lead to limb salvage. If
this cannot be achieved then early amputation prior to
chemotherapy should be considered. If the fracture can be
simply immobilized by minimally invasive surgery, then this
may possibly allow the administration of chemotherapy.
Clearly these suggestions will need adapting for the individ-
ual,anditmaybethatinanolderpatientwithmetastasesand
limited life expectancy, early ﬁxation or an endoprosthetic
replacement may be all that is needed.
Accrual of multicentre data about proximal femoral
pathological fracture due to osteosarcoma may shed further
light into the management of this diﬃcult problem to asses
the potential beneﬁts of early stabilisation or early radical
surgery.
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